-
April 26: The Week in Cancer News
A study indicates that the majority of patients using immune checkpoint inhibitors experience side effects, and radiation oncologists say that requirements for prior authorization are impeding care.
by Kate Yandell
-
April 19: The Week in Cancer News
The CRISPR gene-editing technique is used for the first time in a U.S. cancer clinical trial, and a new targeted therapy is approved for advanced bladder cancer.
by Kate Yandell
-
April 12: The Week in Cancer News
Cancer patients report difficulty getting student loans deferred, and new guidelines for breast cancer screening are released.
by Kate Yandell
-
April 5: The Week in Cancer News
People with metastatic cancer call for more research into survivorship issues facing this group, and a study indicates that taking probiotics may interfere with immunotherapy response.
by Marci A. Landsmann and Kate Yandell
-
Sharing Knowledge, Building Community
The executive editor of Cancer Today previews the new issue.
by Kevin McLaughlin
-
March 22: The Week in Cancer News
A study suggests that 3-D mammograms may reduce unnecessary biopsies, and the U.S. Food and Drug Administration issues warnings to breast implant companies.
by Kate Yandell
-
March 15: The Week in Cancer News
NCI director steps in as FDA commissioner, new guidelines on clinical trial eligibility, and health risks for childhood cancer survivors.
by Bradley Jones
-
March 8: The Week in Cancer News
FDA Commissioner Scott Gottlieb resigns, an analysis explores patient advocacy groups' financial ties, and Alex Trebek announces he has pancreatic cancer.
by Marci A. Landsmann
-
March 1: The Week in Cancer News
A blood test for tumor mutations shows promise as an option for lung cancer patients, and the U.S. Food and Drug Administration expresses concern about robotically-assisted cancer surgery.
by Kate Yandell
-
February 22: The Week in Cancer News
Trials indicate that a combination of a targeted therapy and immunotherapy can treat advanced kidney cancer, and a study identifies a genetic variant associated with smoking menthol cigarettes.
by Kate Yandell
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore